This is a group of rare diseases that can affect different parts of your body. It happens when your body's immune system makes too much of a protein called IgG4. This causes inflammation and scarring in organs like the kidneys, liver, and intestines. Symptoms can vary greatly from person to person.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for IgG4-Related Disease?
IgG4-related disease (IgG4-RD) is a long-term immune condition in which inflammation causes organs to swell and, over time, to scar. The swelling often forms a firm, painless lump or enlarged organ that can look like a tumor on a scan. It usually affects more than one organ, either at the same time or one after another over the years. The organs most often involved are the pancreas and bile ducts, the salivary and tear glands, the tissue around the eyes, the kidneys, and the tissue behind the abdomen and around the aorta (the body's main artery). What a person notices depends on which organs are affected: swollen glands under the jaw or around the eyes, dry mouth, yellowing of the skin from a blocked bile duct, back or abdominal pain, weight loss, or new diabetes when the pancreas is involved. Some people have no symptoms, and the disease is found on a scan done for another reason. The name comes from immunoglobulin G4 (IgG4), a type of antibody. Affected tissue contains many immune cells that make IgG4, and blood levels are often high, but the antibody is better understood as a marker of the disease than as its whole cause. IgG4-RD was recognized as one condition only in the early 2000s; before that, its different forms, such as type 1 autoimmune pancreatitis and some cases of retroperitoneal fibrosis, were treated as separate diseases.
The cause of IgG4-RD is not known. It is considered an immune-mediated disease, meaning the immune system drives inflammation and scarring in the body's own tissues, but researchers have not identified what sets this off or why particular organs are targeted. Unlike most autoimmune conditions, which are more common in women, IgG4-RD affects men about twice as often as women, and it is usually diagnosed between the ages of 50 and 70. Smoking and long-term workplace exposure to dusts, solvents and similar substances have been seen more often in people with the condition, but these are associations, not proven causes. Allergies are common in people with IgG4-RD (in pooled studies, a little under half have them), though it is not clear whether they share the same immune cause. It is a rare disease and is not contagious.
There is no single test for IgG4-RD. Diagnosis brings together symptoms, imaging, blood tests and, in most cases, a tissue sample, and it often takes time: on average, about two years pass between the first symptoms and a diagnosis. A blood test for IgG4 is usually done, and the level is high in many people with the disease. On its own, though, it cannot confirm or rule out IgG4-RD, because some people with the disease have normal levels and raised levels can occur in other conditions, including some cancers and infections. Because the swollen organs can look like cancer, lymphoma, infection or another inflammatory disease, a biopsy (a small tissue sample examined under a microscope) is usually the most important step. It can show the typical pattern of IgG4-producing immune cells and scarring, and, just as importantly, rule out cancer. A CT scan (detailed cross-sectional X-ray imaging) or a PET scan (which highlights areas of active inflammation) of the whole body is often done to find every organ that is involved and to choose the safest place for a biopsy. Doctors also check kidney and liver function and look for other organs that may be affected without causing symptoms yet.
Treatment aims to calm the inflammation before it causes lasting scarring and to prevent flares. Not everyone needs treatment right away: a small, slowly changing lesion that causes no problems may sometimes be watched. When the disease threatens an organ, for example by blocking a bile duct, affecting the kidneys or narrowing the tubes that drain urine, treatment is started promptly, because scarring that has already formed may not reverse. Glucocorticoids (steroid medicines such as prednisone) are the usual first treatment. Most people respond within days to weeks, with swelling shrinking and symptoms easing; a clear response also helps confirm the diagnosis, and a poor response prompts doctors to reconsider it. The dose is then lowered gradually over a few months. The main difficulty is that the disease often comes back as steroids are reduced or stopped, in roughly a third to half of people, and long or repeated steroid courses carry side effects such as higher blood sugar, weight gain and bone thinning that weigh more heavily in older adults. For people who relapse or need to avoid long steroid use, medicines that remove B cells (the immune cells that develop into antibody-producing cells) are now central. Inebilizumab (Uplizna), given as an infusion every six months after two starting doses, is approved by the FDA for adults with IgG4-RD. In a one-year trial, about 10% of people on inebilizumab had a flare compared with 60% on placebo. Rituximab (Rituxan and similar versions), a related infusion, is widely used off-label for the same purpose. Both lower the body's ability to fight infection, so screening for infections such as hepatitis B and tuberculosis comes first, and infections need attention during treatment. Older immune-suppressing tablets, such as mycophenolate or azathioprine, are sometimes used to reduce steroid needs, although evidence for them is limited. Some complications need specific care alongside medicine, such as a stent to open a blocked bile duct or ureter, or treatment for diabetes or poor digestion caused by pancreatic damage.
IgG4-RD usually progresses slowly, and most people respond well to treatment at first. It tends to be a long-term condition with periods of quiet and flares, and a flare may appear in the same organ or in a new one. Some people stay in remission for long periods, while others need ongoing maintenance treatment to stay well. The long-term outlook depends largely on how much scarring has occurred. Damage that builds up before diagnosis or through repeated flares can leave lasting effects, such as reduced pancreatic or kidney function, which may mean managing diabetes, taking enzyme capsules with meals to help digestion, or monitoring kidney health. Follow-up usually involves regular visits, blood tests including IgG4 levels, and repeat imaging to check whether the disease is active and to catch relapses early. Care often involves several specialists, such as a rheumatologist, gastroenterologist or kidney doctor, depending on the organs involved. Studies have found a somewhat higher rate of some cancers, particularly pancreatic cancer and lymphoma, in people with IgG4-RD, so new or unexpected changes on a scan are investigated rather than assumed to be a flare.
See a doctor about lasting, unexplained swelling of the glands under the jaw or around the eyes, a lump found on a scan, or ongoing abdominal or back pain with weight loss, particularly if you have had allergies or other organs affected in the past. If you already have IgG4-RD, tell your care team about any symptom that resembles an earlier flare or affects a new area, rather than waiting for the next scheduled visit. Contact your care team the same day if you notice yellowing of the skin or the whites of the eyes, dark urine or pale stools, which can mean a blocked bile duct, or a sharp drop in how much urine you pass. If you are taking a B-cell treatment or steroids, call promptly about a fever or other signs of infection, since these medicines weaken the immune system.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with IgG4-Related Disease is like, what's helped you, or ask the community a question.